Cell Communication and Signaling (May 2024)

Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia

  • Youyou Li,
  • Jiaren Li,
  • Liang Zhou,
  • Zhenxing Wang,
  • Ling Jin,
  • Jia Cao,
  • Hui Xie,
  • Long Wang

DOI
https://doi.org/10.1186/s12964-024-01644-4
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Benign prostatic hyperplasia (BPH) is a multifactorial disease in which abnormal growth factor activation and embryonic reawakening are considered important factors. Here we demonstrated that the aberrant activation of transforming growth factor β (TGF-β)/Rho kinase 1 (ROCK1) increased the stemness of BPH tissue by recruiting mesenchymal stem cells (MSCs), indicating the important role of embryonic reawakening in BPH. When TGF-β/ROCK1 is abnormally activated, MSCs are recruited and differentiate into fibroblasts/myofibroblasts, leading to prostate stromal hyperplasia. Further research showed that inhibition of ROCK1 activation suppressed MSC migration and their potential for stromal differentiation. Collectively, our findings suggest that abnormal activation of TGF-β/ROCK1 regulates stem cell lineage specificity, and the small molecule inhibitor GSK269962A could target ROCK1 and may be a potential treatment for BPH. Graphical Abstract

Keywords